Nigeria expects to take delivery of 29 million doses of US pharmaceutical company Johnson & Johnson's (NYSE:JNJ) COVID-19 vaccine in August 2021, Reuters news agency reported on Tuesday.
Health Minister Osagie Ehanire was quoted as telling reporters that the single-dose vaccine would be "advantageous" for Nigeria given its partly nomadic population and weak systems for keeping track of people and arranging for second doses.
Ehanire said Nigeria was also expecting four million doses of the Moderna vaccine, 700,000 doses of the AstraZeneca vaccine and an unspecified quantity of Pfizer and Sinopharm doses.
All of these are expected in the third quarter.
According to the most recent data in June 2021, two million people in Nigeria had received one COVID-19 vaccine dose and 700,000 had received two.
So far, in total, Nigeria has so far taken delivery of just under four million vaccine doses.
Virbac expands presence in Japan with Sasaeah acquisition
Pfizer reveals strong efficacy data for ABRYSVO in older adults against RSV
US CDC advisory committee backs Valneva's chikungunya vaccine
Takeda and Biological E. Limited join forces to combat global dengue threat
SK bioscience 'SKYTyphoid' receives WHO prequalification certification
ImmunityBio advances cancer vaccine trial for Lynch syndrome participants
AstraZeneca boosts vaccine portfolio with acquisition of Icosavax
Ultimovacs gains EMA Orphan Drug status for UV1 cancer vaccine in mesothelioma